Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. - Wolfe L; Olivieri N; Sallan D; Colan S; Rose V; Propper R; Freedman MH; Nathan DG (The New England journal of medicine, 1985)